[Suppressor activity of bone marrow cells in patients with stomach neoplasms. Effect of prostaglandins, growth transforming factor-beta, and nitric oxide].
Kusmartseva
I N
IN
Afanas'ev
S G
SG
Cherdyntseva
N V
NV
Kondakova
I V
IV
Kusmartsev
S A
SA
D000911:Antibodies, Monoclonal / Q000276:immunology; D001854:Bone Marrow Cells / Q000276:immunology* / Q000378:metabolism; D002448:Cell Adhesion; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D007963:Leukocytes, Mononuclear / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects; D009569:Nitric Oxide / Q000037:antagonists & inhibitors*; D010835:Phytohemagglutinins / Q000494:pharmacology; D011448:Prostaglandin Antagonists / Q000494:pharmacology; D011453:Prostaglandins / Q000096:biosynthesis*; D013274:Stomach Neoplasms / Q000276:immunology* / Q000378:metabolism; D050378:T-Lymphocytes, Regulatory / Q000276:immunology; D016212:Transforming Growth Factor beta / Q000096:biosynthesis* / Q000276:immunology; D014407:Tumor Cells, Cultured; D019323:omega-N-Methylarginine / Q000494:pharmacology
D000911:Antibodies, Monoclonal; D010835:Phytohemagglutinins; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D016212:Transforming Growth Factor beta; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D007213:Indomethacin